» Articles » PMID: 21153020

Fracture Hospitalizations Between Years 2000 and 2007 in Switzerland: a Trend Analysis

Overview
Journal Osteoporos Int
Date 2010 Dec 15
PMID 21153020
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: In Switzerland, the total number and incidence of hospitalizations for major osteoporotic fractures increased between years 2000 and 2007, while hospitalizations due to hip fracture decreased. The cost impact of shorter hospital stays was offset by the increasing cost per day of hospitalization.

Introduction: The aim of the study was to establish the trends and epidemiological characteristics of hospitalizations for major osteoporotic fractures (MOF) between years 2000 and 2007 in Switzerland.

Methods: Sex- and age-specific trends in the number and crude and age-standardized incidences of hospitalized MOF (hip, clinical spine, distal radius, and proximal humerus) in women and men aged ≥45 years were analyzed, together with the number of hospital days and cost of hospitalization, based on data from the Swiss Federal Statistical Office hospital database and population statistics.

Results: Between 2000 and 2007, the absolute number of hospitalizations for MOF increased by 15.9% in women and 20.0% in men, mainly due to an increased number of non-hip fractures (+37.7% in women and +39.7% in men). Hospitalizations for hip fractures were comparatively stable (-1.8% in women and +3.3% in men). In a rapidly aging population, in which the number of individuals aged ≥45 years grew by 11.1% (women) and 14.6% (men) over the study period, the crude and age-standardized incidences of hospitalizations decreased for hip fractures and increased for non-hip MOF, both in women and men. The length of hospital stay decreased for all MOF in women and men, the cost impact of which was offset by an increase in the daily costs of hospitalization.

Conclusions: Between years 2000 and 2007, hospitalizations for MOF continued to increase in Switzerland, driven by an increasing number and incidence of hospitalizations for non-hip fractures, although the incidence of hip fractures has declined.

Citing Articles

Epidemiology of distal radius fractures in Germany - incidence rates and trends based on inpatient and outpatient data.

Reiland K, Haastert B, Arend W, Kluppelholz B, Windolf J, Icks A Osteoporos Int. 2023; 35(2):317-326.

PMID: 37819401 PMC: 10837268. DOI: 10.1007/s00198-023-06904-6.


Proximal humerus fractures: deltopectoral open reduction and internal fixation vs deltosplit minimally invasive plate osteosynthesis: which surgical approach provides superior results?.

Oldrini L, Sangiorgio A, Feltri P, Marbach F, Filardo G, Candrian C EFORT Open Rev. 2023; 8(8):662-671.

PMID: 37526265 PMC: 10441256. DOI: 10.1530/EOR-22-0110.


Three-Dimensional Measurement of Proximal Humerus Fractures Displacement: A Computerized Analysis.

Ripoll T, Chelli M, Johnston T, Chaoui J, Gauci M, Vasseur H J Clin Med. 2023; 12(12).

PMID: 37373779 PMC: 10299604. DOI: 10.3390/jcm12124085.


Hospitalizations for major osteoporotic fractures in Switzerland: a long-term trend analysis between 1998 and 2018.

Lippuner K, Rimmer G, Stuck A, Schwab P, Bock O Osteoporos Int. 2022; 33(11):2327-2335.

PMID: 35916908 PMC: 9568487. DOI: 10.1007/s00198-022-06481-0.


Opportunistic diagnosis of osteoporotic vertebral fractures on standard imaging performed for alternative indications.

Davy S, Bergin D BJR Open. 2022; 3(1):20210053.

PMID: 35707752 PMC: 9185849. DOI: 10.1259/bjro.20210053.


References
1.
Hulme P, Krebs J, Ferguson S, Berlemann U . Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies. Spine (Phila Pa 1976). 2006; 31(17):1983-2001. DOI: 10.1097/01.brs.0000229254.89952.6b. View

2.
Ettinger B, Black D, Mitlak B, Knickerbocker R, Nickelsen T, Genant H . Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999; 282(7):637-45. DOI: 10.1001/jama.282.7.637. View

3.
Black D, Delmas P, Eastell R, Reid I, Boonen S, Cauley J . Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007; 356(18):1809-22. DOI: 10.1056/NEJMoa067312. View

4.
Orimo H, Yaegashi Y, Onoda T, Fukushima Y, Hosoi T, Sakata K . Hip fracture incidence in Japan: estimates of new patients in 2007 and 20-year trends. Arch Osteoporos. 2010; 4(1-2):71-77. PMC: 2836738. DOI: 10.1007/s11657-009-0031-y. View

5.
Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View